| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049673893 |
| P356 | DOI | 10.1111/J.1523-1755.2005.67097.X |
| P8608 | Fatcat ID | release_3hutfhps7jaztn5zeskysfwjc4 |
| P698 | PubMed publication ID | 15673288 |
| P5875 | ResearchGate publication ID | 8059195 |
| P2093 | author name string | Wilhelm Kriz | |
| Michel LeHir | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 404-419 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Pathways to nephron loss starting from glomerular diseases-insights from animal models | |
| P478 | volume | 67 |
| Q50984066 | 17β-Estradiol (E-2) administration to male (NZB × SWR)F₁ mice results in increased Id(LN)F₁-reactive memory T-lymphocytes and accelerated glomerulonephritis. |
| Q37218316 | 20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in Podocytes |
| Q92978087 | A Clinically Relevant Functional Model of Type-2 Cardio-Renal Syndrome with Paraventricular Changes consequent to Chronic Ischaemic Heart Failure |
| Q39303932 | A High-Content Screening Technology for Quantitatively Studying Podocyte Dynamics |
| Q34021369 | A comparison of nephron number, glomerular volume and kidney weight in Senegalese Africans and African Americans |
| Q37721284 | A conceptual framework for the molecular pathogenesis of progressive kidney disease. |
| Q34455476 | A maladaptive role for EP4 receptors in podocytes |
| Q33637832 | A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype |
| Q85964497 | AKT2 is essential to maintain podocyte viability and function during chronic kidney disease |
| Q50182939 | APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease |
| Q52010401 | AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney. |
| Q39187535 | Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss |
| Q38372746 | Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome |
| Q90007300 | Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss |
| Q33840576 | Acute kidney injury: a springboard for progression in chronic kidney disease |
| Q41905075 | Afferent arteriolopathy and glomerular collapse but not segmental sclerosis induce tubular atrophy in old spontaneously hypertensive rats |
| Q37176748 | Age- and sex-related changes in rat renal function and pathology following neonatal hyperoxia exposure |
| Q37696537 | Age-related histological changes in kidneys of Brown Norway rat. |
| Q37707471 | Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis |
| Q37444731 | Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors? |
| Q43410167 | An inducible mouse model of podocin-mutation-related nephrotic syndrome |
| Q57691243 | Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy |
| Q37085058 | Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease |
| Q34748373 | Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors |
| Q38117018 | Associations between structural and functional changes to the kidney in diabetic humans and mice |
| Q39270044 | B7-1 expression regulates the hypoxia-driven cytoskeleton rearrangement in glomerular podocytes |
| Q51164768 | BXSB-type genome causes murine autoimmune glomerulonephritis: pathological correlation between telomeric region of chromosome 1 and Yaa. |
| Q37943290 | Balancing calcium signals through TRPC5 and TRPC6 in podocytes |
| Q37081774 | Blood pressure follows the kidney: Perinatal influences on hereditary hypertension |
| Q34756227 | Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats |
| Q37230465 | C3G overexpression in glomerular epithelial cells during anti-GBM-induced glomerulonephritis. |
| Q34060349 | CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance |
| Q27692627 | Calcium regulates podocyte actin dynamics |
| Q36083217 | Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl |
| Q40974192 | Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD. |
| Q26853664 | Cell biology and pathology of podocytes |
| Q64062188 | Change in Renal Glomerular Collagens and Glomerular Filtration Barrier-Related Proteins in a Dextran Sulfate Sodium-Induced Colitis Mouse Model |
| Q46667111 | Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies |
| Q51451420 | Clinical outcome of renal tubular damage in chronic heart failure. |
| Q46345674 | Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models |
| Q39406342 | Combined use of electron microscopy and intravital imaging captures morphological and functional features of podocyte detachment |
| Q35597308 | Common histological patterns in glomerular epithelial cells in secondary focal segmental glomerulosclerosis. |
| Q51840923 | Compensatory kidney growth in estrogen receptor-alpha null mice. |
| Q33727877 | Conditionally immortalized human podocyte cell lines established from urine |
| Q38742097 | Dact1, a Wnt-Pathway Inhibitor, Mediates Human Mesangial Cell TGF-β1-Induced Apoptosis |
| Q37278421 | Diabetic albuminuria is due to a small fraction of nephrons distinguished by albumin-stained tubules and glomerular adhesions. |
| Q38857652 | Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)? |
| Q26996008 | Diabetic nephropathy and extracellular matrix |
| Q84199274 | Differential contribution of diabetes and the Ren2 gene to glomerular pathology in diabetic (mREN-2)27 rats |
| Q34839515 | Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy |
| Q38203904 | Dipping your feet in the water: podocytes in urine |
| Q37887350 | Distribution of volumes of individual glomeruli in kidneys at autopsy: association with physical and clinical characteristics and with ethnic group |
| Q50508580 | Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice. |
| Q37051475 | Dual effects of RAS blockade on blood pressure and podocyte function |
| Q48569238 | Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes |
| Q33888418 | Early renal abnormalities in autosomal dominant polycystic kidney disease |
| Q89288961 | Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor |
| Q36346080 | Effect of methanolic fraction of Kalanchoe crenata on metabolic parameters in adriamycin-induced renal impairment in rats |
| Q46827214 | Effects of a reduction in maternal renal mass on pregnancy and cardiovascular and renal function of the pregnant ewe. |
| Q41905147 | Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease |
| Q39527086 | Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes |
| Q52720504 | Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury. |
| Q37849269 | Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? |
| Q80800796 | Epithelial-mesenchymal transition (EMT) of renal tubular cells in canine glomerulonephritis |
| Q37733611 | Estimating podocyte number and density using a single histologic section |
| Q34556186 | Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications |
| Q28084462 | Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances |
| Q34663452 | Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney |
| Q82568563 | Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy |
| Q37733584 | Extensive podocyte loss triggers a rapid parietal epithelial cell response |
| Q38391570 | Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression |
| Q40589678 | Fully Automated Evaluation of Total Glomerular Number and Capillary Tuft Size in Nephritic Kidneys Using Lightsheet Microscopy |
| Q36314908 | Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective |
| Q87370524 | Glomerular diseases: podocyte hypertrophy mismatch and glomerular disease |
| Q51719210 | Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter rats. |
| Q51780943 | Glomerular involution in children with frequently relapsing minimal change nephrotic syndrome: an unrecognized form of glomerulosclerosis? |
| Q80186566 | Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1) |
| Q30444355 | Glomerulotubular disconnection in neonatal mice after relief of partial ureteral obstruction |
| Q36773725 | Growth hormone (GH)-transgenic insulin-like growth factor 1 (IGF1)-deficient mice allow dissociation of excess GH and IGF1 effects on glomerular and tubular growth |
| Q36109205 | Growth-dependent podocyte failure causes glomerulosclerosis |
| Q36588493 | HDAC inhibitors in experimental liver and kidney fibrosis |
| Q38838116 | Hippo signaling in the kidney: the good and the bad. |
| Q41514486 | Histopathological characteristics of renal changes in human renin-angiotensinogen double transgenic rats |
| Q43251634 | How are podocytes affected in nail-patella syndrome? |
| Q33399420 | Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease |
| Q36638347 | IgM contributes to glomerular injury in FSGS |
| Q31082876 | Increased cardiovascular and renal risk is associated with low nephron endowment in aged females: an ovine model of fetal unilateral nephrectomy |
| Q46976925 | Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. |
| Q35804206 | Increased tubular proliferation as an adaptive response to glomerular albuminuria |
| Q37313920 | Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis |
| Q36604421 | Intrarenal oxygenation in chronic renal failure |
| Q34508263 | Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations. |
| Q35895028 | Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury |
| Q24298682 | Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys |
| Q49617855 | Kidney Appreciates Stable Blood Pressure. |
| Q37170815 | Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury |
| Q30442482 | Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury |
| Q36586503 | Lipotoxicity |
| Q43272251 | Loss of renal microvascular integrity in postnatal Crim1 hypomorphic transgenic mice |
| Q37806973 | Maternal undernutrition and the offspring kidney: from fetal to adult life |
| Q38786437 | Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis |
| Q35649310 | Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease |
| Q36577077 | Mechanisms of disease: focal segmental glomerulosclerosis |
| Q92914442 | Mechanisms of haemolysis-induced kidney injury |
| Q46594445 | Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation. |
| Q42434881 | Mesangial cells are responsible for orchestrating the renal podocytes injury in the context of malignant hypertension |
| Q91753945 | Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states |
| Q46287968 | Morphological characterization of ckd in cats: Insights of fibrogenesis to be recognized. |
| Q34489355 | Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease |
| Q50511874 | Mouse model of proximal tubule endocytic dysfunction. |
| Q46598157 | New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure |
| Q64902412 | Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation. |
| Q34373905 | Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders |
| Q35840462 | Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes |
| Q22241459 | Obesity and Risk for Chronic Renal Failure |
| Q38846753 | Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. |
| Q35994534 | PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis |
| Q36371099 | Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. |
| Q38111707 | Pathophysiology of the diabetic kidney. |
| Q38870270 | Pleiotropic signaling evoked by tumor necrosis factor in podocytes |
| Q64889198 | Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies. |
| Q28256662 | Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome |
| Q36021415 | Podocyte Depletion in Thin GBM and Alport Syndrome |
| Q36822354 | Podocyte Detachment Is Associated with Renal Prognosis in ANCA-Associated Glomerulonephritis: A Retrospective Cohort Study |
| Q42107349 | Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be Pharmacologically Enhanced |
| Q41921297 | Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies |
| Q44010767 | Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria? |
| Q38061941 | Podocyte mitosis - a catastrophe. |
| Q37723409 | Podocyte number and density changes during early human life |
| Q26766118 | Podocytes |
| Q38371649 | Podocytes … What's Under Yours? (Podocytes and Foot Processes and How They Change in Nephropathy). |
| Q26799182 | Podometrics as a Potential Clinical Tool for Glomerular Disease Management |
| Q39464387 | Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis |
| Q35234337 | Progression of glomerular and tubular disease in pediatrics |
| Q48636042 | Proliferative and nonproliferative lesions of the rat and mouse urinary system |
| Q37668154 | Proteinuria and events beyond the slit |
| Q38057664 | Proteinuria and progression of glomerular diseases |
| Q33943310 | Proteinuria: an enzymatic disease of the podocyte? |
| Q89658994 | Proteomic Analysis of Human Serum from Patients with Chronic Kidney Disease |
| Q35005734 | Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria |
| Q30999305 | Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis |
| Q36972412 | Quantitative podocyte parameters predict human native kidney and allograft half-lives |
| Q24308871 | Regeneration of glomerular podocytes by human renal progenitors |
| Q46301431 | Regression of glomerular injury by losartan in experimental diabetic nephropathy. |
| Q37228467 | Remnant nephron physiology and the progression of chronic kidney disease |
| Q36412414 | Renal albumin absorption in physiology and pathology |
| Q38359455 | Renal allograft fibrosis: biology and therapeutic targets |
| Q38038950 | Renal biopsy findings among Indigenous Australians: a nationwide review |
| Q50097164 | Renal fibrosis: Primacy of the proximal tubule |
| Q37788542 | Renal fibrosis: novel insights into mechanisms and therapeutic targets. |
| Q35967489 | Renal interstitial fibrosis: mechanisms and evaluation |
| Q51759732 | Renal pathology and urinary protein excretion in a 14-month-old Bernese mountain dog with chronic renal failure. |
| Q41549740 | Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate–salt hypertensive mice |
| Q82715862 | Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis |
| Q33737251 | Renal tubular angiogenic dysregulation in anti-Thy1.1 glomerulonephritis |
| Q90353253 | Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats |
| Q46064887 | Salt-resistant blood pressure and salt-sensitive renal autoregulation in chronic streptozotocin diabetes |
| Q28505175 | Screening for increased plasma urea levels in a large-scale ENU mouse mutagenesis project reveals kidney disease models |
| Q36778197 | Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model. |
| Q38931612 | Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin, vimentin, podocin, synaptopodin and WT-1 in acute and chronic rat kidney disease models |
| Q90597684 | Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis |
| Q46735579 | Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury |
| Q38350669 | Sickle cell disease: renal manifestations and mechanisms |
| Q41499068 | Single and Transient Ca(2+) Peaks in Podocytes do not induce Changes in Glomerular Filtration and Perfusion |
| Q38305318 | Snail, a transcriptional regulator, represses nephrin expression in glomerular epithelial cells of nephrotic rats |
| Q88345710 | Sodium bicarbonate loading limits tubular cast formation independent of glomerular injury and proteinuria in Dahl salt-sensitive rats |
| Q45072496 | Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases |
| Q36232369 | Statins and proteinuria |
| Q34687329 | Structural analysis of how podocytes detach from the glomerular basement membrane under hypertrophic stress |
| Q37607104 | T cell cross-talk with kidney dendritic cells in glomerulonephritis |
| Q87663022 | TBX3, a downstream target of TGF-β1, inhibits mesangial cell apoptosis |
| Q42531545 | TGF-β and renal fibrosis: a Pandora's box of surprises |
| Q34211578 | TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology |
| Q89985512 | TRPC6 inactivation does not protect against diabetic kidney disease in streptozotocin (STZ)-treated Sprague-Dawley rats |
| Q35187418 | TWEAK/Fn14 system and crescent formation in IgA nephropathy |
| Q38264230 | Tessellation analysis of glomerular spatial arrangement in mice with heritable renal hypoplasia |
| Q53036315 | The effect of connective tissue growth factor on renal fibrosis and podocyte injury in hypertensive rats. |
| Q34021381 | The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney |
| Q34307043 | The emerging role of the inflammasome in kidney diseases |
| Q31157183 | The expression and significance of neuronal iconic proteins in podocytes |
| Q38605695 | The glycocalyx--linking albuminuria with renal and cardiovascular disease |
| Q38137749 | The immune system and kidney disease: basic concepts and clinical implications. |
| Q41308457 | The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes |
| Q79744879 | The not-so-minimal lesions of the idiopathic nephrotic syndrome of childhood |
| Q42235250 | The origin of renal fibroblasts and progression of kidney disease |
| Q30276784 | The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction |
| Q37199012 | The renal cortical interstitium: morphological and functional aspects |
| Q35658590 | The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective |
| Q37089424 | Transforming growth factor-beta and the glomerular filtration barrier |
| Q43266632 | Transgenic mice expressing nitroreductase gene under the control of the podocin promoter: a new murine model of inductible glomerular injury |
| Q48444056 | Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice |
| Q35738438 | Transient impairment of dynamic renal autoregulation in early diabetes mellitus in rats |
| Q34354544 | Trophoblast glycoprotein: possible candidate mediating podocyte injuries in glomerulonephritis |
| Q38553671 | Tubular atrophy in the pathogenesis of chronic kidney disease progression |
| Q38867061 | Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis |
| Q34033449 | Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells |
| Q92129277 | Tubuloids derived from human adult kidney and urine for personalized disease modeling |
| Q52762400 | Tubulointerstitial fibrosis can sensitize the kidney to subsequent glomerular injury. |
| Q26852862 | Tubulointerstitial injury and the progression of chronic kidney disease |
| Q30448126 | Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy |
| Q45730002 | Urinary and glomerular podocytes in patients with chronic kidney diseases |
| Q36389219 | Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker |
| Q37182003 | Urine podocyte mRNAs mark progression of renal disease |
| Q37340215 | Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases |
| Q34206971 | Using zebrafish to study podocyte genesis during kidney development and regeneration |
| Q53134308 | Validation of an Experimental Model to Study Less Severe Chronic Renal Failure. |
| Q36765221 | What is damaging the kidney in lupus nephritis? |
| Q36928907 | Yes-associated protein (YAP) promotes cell survival by inhibiting proapoptotic dendrin signaling |
Search more.